Skip to main content

Table 1 The demographical characteristics and smoking habits of participants

From: A comparison of the efficacy of varenicline and bupropion and an evaluation of the effect of the medications in the context of the smoking cessation programme

Variable

Varenicline (n = 244)

Bupropion (n = 161)

p*

n

%

n

%

Gender

Male (n = 334)

194

79.5

140

87.0

0.054

Female (n = 71)

50

20.5

21

13.0

Age Groups

20–29 (n = 111)

74

30.3

37

23.0

0.267

30–39 (n = 184)

106

43.4

78

48.4

≥40 (n = 110)

64

26.2

46

28.6

Marital Status

Married (n = 329)

191

78.3

138

85.7

0.061

Not Married (n = 76)

53

21.7

23

14.3

Educational Status

Primary- Secondary

45

18.4

31

19.3

0.775

High School

101

41.4

71

44.1

College + a

98

40.2

59

36.6

Alcohol Consumption Status

Yes (n = 63)

37

15.2

26

16.163

0.789

No (n = 342)

207

84.8

135

83.9

Social support

Yes (n = 241)

169

69.3

75

65.2

0.394

No (n = 161)

75

30.7

86

34.8

The amount of cigarettes smoked per day in the initial presentation

1–10 pcs

29

11.9

5

3.1

0.004

11–20 pcs

99

40.6

86

53.4

21–30 pcs

79

53.4

43

26.7

≥31 pcs

37

45.7

27

16.8

Previous quitting trial

Yes (n = 272)

167

68.4

105

65.2

0.499

No (n = 133)

77

31.6

56

34.8

Concerns about the harmful effects of smoking

No (n = 24)

16

6.6

8

5.0

0.532

Little (n = 69)

45

18.4

24

14.9

High (n = 170)

96

39.3

74

46.0

Very High (n = 142)

87

35.7

55

34.2

Mean Fagerstrom Score

6.34 ± 2.38

6.23 ± 2.49

0.655**

The amount of cigarettes/day in the initial presentation

22.78 ± 10.11

23.39 ± 9.13

0.540

Mean Age

34.8 ± 7.61

35.9 ± 7.78

0.124

Mean age of start to begin smoking

17.80 ± 4.26

17.60 ± 4.35

0.635

Mean Body Mass Index

25.46 ± 3.80

26.11 ± 3.59

0.082

  1. *Chi square test, **Independent sample t test (in evaluation of mean values)
  2. aCollege graduate or bachelor’s degree